Nostopharma
Nostopharma is a company focused on restoring orthopedic patients to health through targeted therapy. They are currently in the pre-clinical stage of developing small molecule targeted therapy for trauma-induced abnormal bone growth.
Industries
health-care
medical
medical-device
Nr. of Employees
small (1-50)
Nostopharma
Bethesda, Maryland, United States, North America
Products
Small-molecule therapeutic candidate for trauma-induced abnormal bone growth
A preclinical-stage small-molecule drug candidate intended to prevent or reduce abnormal bone formation following trauma, developed using a targeted therapy approach.
Small-molecule therapeutic candidate for trauma-induced abnormal bone growth
A preclinical-stage small-molecule drug candidate intended to prevent or reduce abnormal bone formation following trauma, developed using a targeted therapy approach.
Expertise Areas
- Therapeutic small-molecule development
- Preclinical development for orthopedic indications
- Targeted therapy design
- Program documentation for investors and partners
Key Technologies
- Small-molecule therapeutics
- Targeted therapy design
- Preclinical efficacy models
- Orthopedic disease models